Vivo Opportunity Fund Holdings, L.P. - 31 Mar 2025 SCHEDULE 13G/A Report for Soleno Therapeutics, Inc. Common Stock, $0.001 par value per share (SLNO)

Filing Manager: Vivo Opportunity Fund Holdings, L.P.
Reporting Manager: Vivo Opportunity Fund Holdings, L.P.
Security: Soleno Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol: SLNO
Shares outstanding: 45,961,794 shares
Disclosed Ownership: 4,458,294 shares
Ownership: 9.7%
Form type: SCHEDULE 13G/A
Filing time: 31 Mar 2025, 20:00:57 UTC
Date of event: 31 Mar 2025
Next filing: 12 Aug 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Vivo Opportunity Fund Holdings, L.P.	9.7%	4,458,294	4,458,294	0	/s/ Kevin Dai	Kevin Dai\Managing Member
Vivo Opportunity, LLC	9.7%	4,458,294	4,458,294	0	/s/ Kevin Dai	Kevin Dai\Managing Member